Home / Health / Stopping GLP-1s? Your Heart Health Risks
Stopping GLP-1s? Your Heart Health Risks
4 Oct
Summary
- Stopping GLP-1s causes gradual loss of benefits, not immediate heart attack.
- Cardiovascular benefits from GLP-1s typically do not last after stopping.
- Consult a doctor before stopping GLP-1 medication for health reasons.
When individuals stop taking GLP-1 medications, the positive effects on blood sugar, appetite, and weight diminish gradually. While an immediate heart attack is not a direct consequence of stopping, the risk factors that these medications helped manage may resurface over time. This includes potential weight regain, increased blood sugar levels, and elevated blood pressure.
Cardiovascular benefits observed during GLP-1 treatment, such as reduced major cardiovascular events seen with drugs like semaglutide, are generally not sustained after medication cessation. Evidence suggests that stopping weight-management drugs can lead to significant weight regain and a reversal of some cardiometabolic improvements. The duration of cardiovascular protection post-discontinuation varies among individuals.
It is strongly advised against discontinuing GLP-1 medicines independently. Consultation with a prescribing physician is essential for a planned and safe cessation. Doctors can assess reasons for stopping, such as side effects or cost, and determine alternative management strategies, like dose adjustments or different medications, to maintain health improvements.
